The tie up aims for the development of practical synthetic routes to complex natural products of importance for the treatment of skin diseases.
LEO Pharma New Product Discovery senior vice president Tore Duvold said they are delighted to enter into collaboration with Professor Baran’s group at The Scripps Research Institute.
"Our goal is to share knowledge and achieve findings that can be directly applied to LEO Pharma’s research and development within dermatology," Duvold said.